Stockscreener 앱 받기
0.00
100.00%
-7.35
전일 마감가:
$7.35
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$2.73B
수익:
$3.49M
순이익/손실:
$-663.48M
주가수익비율:
0.00
EPS:
-2.2387
순현금흐름:
$-115.08M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$7.45
Ataibeckley Inc Stock (ATAI) Company Profile
명칭
Ataibeckley Inc
전화
1 929 207 2670
주소
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Compare ATAI vs VRTX, REGN, MRNA, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
0.00 | 2.73B | 3.49M | -663.48M | -115.08M | -2.2387 |
VRTX
Vertex Pharmaceuticals Inc
|
521.23 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.49 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
193.91 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
958.75 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.30 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | Deutsche Bank | Buy |
| 2026-01-20 | 개시 | Guggenheim | Buy |
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-07-29 | 개시 | Oppenheimer | Outperform |
| 2024-11-18 | 재확인 | H.C. Wainwright | Buy |
| 2024-04-03 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
| 2021-11-11 | 개시 | ROTH Capital | Buy |
| 2021-10-18 | 개시 | H.C. Wainwright | Buy |
| 2021-09-01 | 개시 | Jefferies | Buy |
| 2021-07-13 | 개시 | Berenberg | Buy |
| 2021-07-13 | 개시 | Canaccord Genuity | Buy |
| 2021-07-13 | 개시 | Cantor Fitzgerald | Buy |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-13 | 개시 | Credit Suisse | Outperform |
| 2021-07-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 개시 | Aegis Capital | Buy |
모두보기
Ataibeckley Inc 주식(ATAI)의 최신 뉴스
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly - Stocktwits
Why Is ATAI Stock Soaring 59% After-Hours? - Stocktwits
Why Did AAPL, ATAI, UNH Stocks Jump To 52-Week Highs Today? - Stocktwits
Enterprise value to EBIT forward of AtaiBeckley Inc. – BIVA:ATAI - TradingView
AtaiBeckley's Final Chapter: Shareholders Trade Certainty for Milestone-Linked Upside - AD HOC NEWS
AtaiBeckley Inc. SEC Filing (Sep 21, 2026) - Stock Titan
Enterprise value to EBITDA forward of AtaiBeckley Inc. – GETTEX:B72 - tradingview.com
AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a 10.43% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
AtaiBeckley Inc. Insider Barrett Christopher Ryan Cave Sells Entire Stake of 155,066 Shares (NASDAQ: ATAI) - Kalkine Media
Eli Lilly Completes AtaiBeckley Acquisition - Contract Pharma
Eli Lilly completes AtaiBeckley (ATAI) buyout, major backer exits - Stock Titan
Lilly completes acquisition of AtaiBeckley for mental health drugs By Investing.com - Investing.com Australia
Form 8K ATAI Beckley Inc For: 11 September By Investing.com - Investing.com Nigeria
Eli Lilly now owns AtaiBeckley (NASDAQ: ATAI) after merger - Stock Titan
Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions - Investing News Network
Nasdaq removes AtaiBeckley (Nasdaq: ATAI) common stock from listing - Stock Titan
Lilly Completes AtaiBeckley Acquisition to Expand Mental Health Pipeline - citybiz
Eli Lilly Closes $6.75-Per-Share AtaiBeckley Buyout - Minichart
Eli Lilly completes acquisition of AtaiBeckley, initiates delisting from Nasdaq By Investing.com - Investing.com Canada
After Eli Lilly deal, AtaiBeckley (ATAI) pulls remaining employee stock from SEC registration - Stock Titan
Eli Lilly (NYSE: LLY) now owns all of AtaiBeckley (NASDAQ: ATAI) - Stock Titan
Eli Lilly completes acquisition of AtaiBeckley, initiates delisting from Nasdaq - investing.com
Form 8K ATAI Beckley Inc For: 11 September - Investing.com India
Eli Lilly Completes Acquisition of AtaiBeckley - marketscreener.com
AtaiBeckley Announced Transfer or Voluntary Withdrawal of Listing - TradingView
AtaiBeckley (NASDAQ: ATAI) investors get cash now—and a shot at more in Lilly takeover - Stock Titan
Lilly completes acquisition of AtaiBeckley for mental health drugs - investing.com
Eli Lilly Finalizes Acquisition of AtaiBeckley Inc. in Merger Deal - Kalkine Media
Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report? - Yahoo Finance
COSCIENS Biopharma Inc. acquired IntelGenx Technologies Corp. from AtaiBeckley Inc. for $9 million. - marketscreener.com
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too? - Stocktwits
AtaiBeckley Inc. (ATAI) News, Articles, Events & Latest Updates - Stocktwits
AtaiBeckley Inc.(NasdaqGM: ATAI) dropped from S&P Pharmaceuticals Select Industry Index - marketscreener.com
AtaiBeckley Inc.(NasdaqGM: ATAI) dropped from S&P TMI Index - marketscreener.com
AtaiBeckley Inc.(NasdaqGM: ATAI) dropped from S&P Global BMI Index - marketscreener.com
AtaiBeckley Inc.(NasdaqGM: ATAI) dropped from NASDAQ Biotechnology Index - marketscreener.com
Shareholders clear Lilly merger for AtaiBeckley (ATAI), with closing still subject to conditions - Stock Titan
ATAI: Merger agreement with Eli Lilly and Company received shareholder approval - TradingView
ATAI: Merger agreement with Eli Lilly and Company approved by shareholders; all proposals passed - TradingView
AtaiBeckley Inc.(NasdaqGM: ATAI) dropped from Russell 2500 Growth Index - marketscreener.com
AtaiBeckley Inc.(NasdaqGM: ATAI) dropped from Russell 2500 Dynamic Index - marketscreener.com
Atai Beckley (NASDAQ:ATAI) Clears Minervini Trend Template and High-Growth Momentum Screen - ChartMill
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates A - The National Law Review
Jim Cramer Isn't Sure If There’s Upside In This Health Care Stock - Benzinga
AtaiBeckley merger with Eli Lilly clears HSR waiting period; UK, Australia reviews progressing - TradingView
Ataibeckley Hart-Scott-Rodino Waiting Period For Eli Lilly Merger Expired August 28 - TradingView
Lilly–AtaiBeckley (NASDAQ: ATAI) merger clears hurdles, not the finish line - Stock Titan
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc.ATAI - Sahm
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates - GuruFocus
Eli Lilly-AtaiBeckley deal approved in Australia - MLex
ATAI Beckley earnings up next in final report before acquisition - Investing.com
Ataibeckley Inc (ATAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.21%
1.05%
자본화:
|
볼륨(24시간):